This study, based on the FAERS database, identified signals related to AKI associated with two PCSK9 inhibitors, Evolocumab and Alirocumab, revealing the protective effect of PCSK9 inhibitors against AKI. The gene discussed is PCSK9; the disease is acute kidney injury.